-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompilationTom Lee
Recently, according to a warning notice sent by GlaxoSmithKline (GSK) to the Tennessee Department of Labor and Workforce Development, the company has decided to close its manufacturing plant in Memphis, Tennessee, and 156 employees will face unemployment
GSK pointed out that the layoff plan has been brewing for some time
A few years ago, another GSK spokesperson said in an interview with foreign media Fierce Pharma that the Memphis factory, which mainly produces Polident denture cleaning products and other oral brands, opened in 1964
In the end, GSK sold 17 North American market drug assets to Prestige Brands for $660 million
The unsold Memphis plant received a $2 million investment in 2015 to upgrade its infrastructure
The company said in the factory shutdown alert that the rapid response team of the local labor development zone in Memphis has begun to handle the case and provide coordination services with its employees at GSK
At the end of last month, GSK announced the company's operations and R&D plans for the next 10 years at an investor event
Although the company is currently in the process of business spin-off and reorganization, GSK did not provide specific reasons for the closure of the Memphis plant and a new round of layoffs
Reference source: GlaxoSmithKline to close Memphis consumer health plant, putting 150 jobs on the chopping block